학술논문

The Apolipoprotein E neutralizing antibody inhibits SARS‐CoV‐2 infection by blocking cellular entry of lipoviral particles.
Document Type
Article
Source
MedComm; Oct2023, Vol. 4 Issue 5, p1-15, 15p
Subject
APOLIPOPROTEIN E
SARS-CoV-2
IMMUNOGLOBULINS
ANTIVIRAL agents
LOW density lipoprotein receptors
Language
ISSN
26882663
Abstract
Copyright of MedComm is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)